Ayse Nuransoy Cengiz

8PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Nutrigenomics and personalised nutritionCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 27, 2026
Receptor Status Changes, HER2-Low Discordance, and TNBC Transformation in Metastatic Breast Cancer: Prognostic Significance and Impact on Survival Outcomes.

|Aug 27, 2026
Demographic Characteristics, Clinical Features, and Treatment Patterns of Classic and AIDS-Related Kaposi Sarcoma: A Multicenter Real-World Study from Turkey.

|Aug 20, 2026
The role of the prognostic nutritional index at baseline and follow-up in patients with metastatic prostate cancer.

|Jul 28, 2026
Comparison of Neoadjuvant TCHP and ddAC+THP Regimens for Pathologic Complete Response in HER2-Positive Breast Cancer: A Multicenter Real-World Analysis of Systemic Inflammatory Biomarkers.

|May 08, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

Pageof 2

Frequent Collaborators

5 joint publications

Oktay Bozkurt

4 joint publications

Deniz Can Guven

4 joint publications

Emel Mutlu Ozkan

4 joint publications

Metin Ozkan